BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14608142)

  • 1. Considerations on radiation source selection and utilization in vascular brachytherapy.
    Crocker I
    J Invasive Cardiol; 2003 Nov; 15(11):664-7; quiz 668. PubMed ID: 14608142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
    Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
    Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular brachytherapy and the strontium90 vascular brachytherapy system.
    Reisman M; Gray WA
    J Invasive Cardiol; 2003 Sep; 15(9):520-2; quiz 523. PubMed ID: 12947213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary brachytherapy for the treatment of complex in-stent restenosis.
    Cotton JM; Rance K; Patil A; Thomas MR
    Heart; 2005 Feb; 91(2):231-2. PubMed ID: 15657245
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose mapping of porcine coronary arteries using an optical fiber dosimeter.
    Dilcher C; Chan R; Justus BL; Falkenstein P; Huston AL; Waksman R
    Cardiovasc Revasc Med; 2005; 6(4):163-9. PubMed ID: 16326378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brachytherapy for coronary restenosis: state of art in 2003].
    Latorzeff I; Carrie D; Alibelli MJ; Bonnet J; Duthil P; Delannes M
    Cancer Radiother; 2003 Feb; 7(1):50-61. PubMed ID: 12648717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy.
    Kirisits C; Pokrajac B; Berger D; Minar E; Pötter R; Georg D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1652-9. PubMed ID: 15590198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation.
    Saghamanesh S; Karimian A; Abdi M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):296-9. PubMed ID: 21831866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose perturbation caused by stents: experiments with a model 90Sr/90Y source.
    Wilczek K; Petelenz B; Strzała A; Marczewska B; Traczyk M; Poloński L
    Cardiovasc Intervent Radiol; 2007; 30(5):981-91. PubMed ID: 17710473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis after angioplasty.
    Cannon RO
    N Engl J Med; 2002 Apr; 346(16):1182-3. PubMed ID: 11961145
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
    Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
    Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect on dose owing to source displacement in coronary endovascular brachytherapy].
    Xu ZY; Zhang LA; Yuan SY; Dai GF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):193-6. PubMed ID: 12905719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular radiotherapy for stenosis after percutaneous transluminal coronary angioplasty.
    Ulutin HC; Pak Y
    Radiat Med; 2001; 19(4):175-9. PubMed ID: 11550716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis.
    Bagga R; Kini A; Lee P; Agarwal A; Duffy M; Kim M; Sharma S
    J Invasive Cardiol; 2005 Jun; 17(6):302-6. PubMed ID: 16003004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and mechanisms of intracoronary manual stepping brachytherapy as gained from serial angiographic and intravascular ultrasound studies.
    Schiele TM; König A; Zimmermann A; Krötz F; Sohn HY; Rieber J; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Siebert U; Klauss V
    Am J Cardiol; 2002 Dec; 90(12):1385-8. PubMed ID: 12480051
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution?
    Nikolsky E; Gruberg L; Rosenblatt E; Grenadier E; Boulos M; Bernstein Z; Huber A; Gitman R; Bar-Deroma R; Markiewicz W; Beyar R
    Int J Cardiovasc Intervent; 2004; 6(1):33-8. PubMed ID: 15204171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.